Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
Recruiting
N/A
Interventional Study
Neuromuscular Diseases
Obesity (Disorder)
Myotonic Dystrophy 1
Myasthenic Syndrome
Charcot Marie Tooth Disease (CMT)
Glycogen Storage Disease Type II Pompe Disease
Facio-Scapulo-Humeral Dystrophy
Myasthenia Gravis
Huntington Disease
Progressive Supranuclear Palsy (PSP)
Hereditary Spastic Paraplegia
Ataxia, Spinocerebellar
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 300 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Liege · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The ActiLiège-Adult study is a prospective, longitudinal, observational study designed to collect natural history data on adult patients with neurological or metabolic diseases affecting movement. Conducted at the Centre de Référence Liégeois des Maladies Neuromusculaires in Liège, Belgium, the study will enroll 300 ambulant patients, including individuals with neuromuscular disorders and obesity.…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Ambulant patients (i.e. able to walk 10 meters without assistance)
* Confirmed diagnosis by the investigator based on current gold standard in his/her disease (genetic testing, clinical criteria, etc.)
* Myotonic dystrophy type 1 (DM1) and Charcot-Marie-Tooth (CMT) patients…
Contacts